PROSPECTIVE RANDOMIZED TRIAL COMPARING PEGIFNALPHA 2A AND PEGIFN ALPHA 2B WITH RIBAVIRIN IN HCV-LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C

被引：0
|
作者：
Aguilera, V. [1 ,2 ]
Prieto, M. [1 ,2 ]
Rubin, A. [1 ,2 ]
Risalde, B. [1 ,2 ]
Ortiz Canto, C. [2 ,3 ]
Berenguer, M. [1 ,2 ]
机构：
[1] Hosp Univ La Fe, Serv Hepatogastroenterol, Valencia, Spain
[2] Inst Salud Carlos III, CIBEREHD, Valencia, Spain
[3] Hosp La Fe, Expt Immun Unit, E-46009 Valencia, Spain
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [21] Impact of pegylated interferon alfa-2b and ribavirin on depression in liver transplant recipients with recurrent hepatitis C
    Challis, M
    Rogge, J
    Weaver, L
    Mukherjee, S
    GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [22] Interferon-alfa2B and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    Rakela, J
    HEPATOLOGY, 1999, 30 (04) : 656A - 656A
  • [23] Interferon-alfa2b and ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C.
    Shakil, AO
    McGuire, B
    Crippin, JS
    Canjeevaram, HS
    Teperman, L
    Gish, RG
    Kwo, P
    Wright, TL
    Brass, C
    Balan, V
    Demetris, J
    Rakela, J
    HEPATOLOGY, 2000, 32 (04) : 216A - 216A
  • [24] A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C
    Jain, A
    Kashyap, R
    Demetris, AJ
    Eghstesad, B
    Pokharna, R
    Fung, JJ
    LIVER TRANSPLANTATION, 2002, 8 (01) : 40 - 46
  • [25] PEGIFNα-2A PLUS RIBAVIRIN SHOWS HIGHER SVR RATE COMPARE WITH PEGIFNα-2B PLUS RIBAVIRIN IN ELDERLY PATIENTS WITH CHRONIC HEPATITIS C SPECIALLY IN IL-28B MAJOR ALLELE
    Miyase, S.
    Morishita, Y.
    Haraoka, K.
    Ouchida, Y.
    Fujiyama, S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S451 - S451
  • [26] A prospectivE randomized trial comparing lymphoblastoid to recombinant alpha 2a interferon as therapy of chronic hepatitis C.
    Rumi, MG
    DelNinno, E
    Parravicini, ML
    Romeo, R
    Soffredini, R
    Donato, MF
    Wilber, J
    Russo, A
    Colombo, M
    HEPATOLOGY, 1996, 24 (04) : 591 - 591
  • [27] A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
    Angelico, Mario
    Petrolati, Alessandra
    Lionetti, Raffaella
    Lenci, Ilaria
    Burra, Patrizia
    Donato, Maria Francesca
    Merli, Manuela
    Strazzabosco, Mario
    Tisone, Giuseppe
    JOURNAL OF HEPATOLOGY, 2007, 46 (06) : 1009 - 1017
  • [28] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [29] Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplant recipients:: A prospective, randomized, controlled trial
    Singh, N
    Gayowski, T
    Wannstedt, CF
    Shakil, AO
    Wagener, MM
    Fung, JJ
    Marino, IR
    TRANSPLANTATION, 1998, 65 (01) : 82 - 86
  • [30] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    TRANSPLANTATION, 2000, 69 (08) : S265 - S265
12345